These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 16357178

  • 1. Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models.
    Pchejetski D, Golzio M, Bonhoure E, Calvet C, Doumerc N, Garcia V, Mazerolles C, Rischmann P, Teissié J, Malavaud B, Cuvillier O.
    Cancer Res; 2005 Dec 15; 65(24):11667-75. PubMed ID: 16357178
    [Abstract] [Full Text] [Related]

  • 2. Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models.
    Pchejetski D, Doumerc N, Golzio M, Naymark M, Teissié J, Kohama T, Waxman J, Malavaud B, Cuvillier O.
    Mol Cancer Ther; 2008 Jul 15; 7(7):1836-45. PubMed ID: 18644996
    [Abstract] [Full Text] [Related]

  • 3. Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel.
    Sauer L, Nunes J, Salunkhe V, Skalska L, Kohama T, Cuvillier O, Waxman J, Pchejetski D.
    Int J Cancer; 2009 Dec 01; 125(11):2728-36. PubMed ID: 19521959
    [Abstract] [Full Text] [Related]

  • 4. FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.
    Pchejetski D, Bohler T, Brizuela L, Sauer L, Doumerc N, Golzio M, Salunkhe V, Teissié J, Malavaud B, Waxman J, Cuvillier O.
    Cancer Res; 2010 Nov 01; 70(21):8651-61. PubMed ID: 20959468
    [Abstract] [Full Text] [Related]

  • 5. Bioactive sphingolipids in docetaxel-induced apoptosis in human prostate cancer cells.
    Bassoy EY, Baran Y.
    Biomed Pharmacother; 2012 Mar 01; 66(2):103-10. PubMed ID: 22326625
    [Abstract] [Full Text] [Related]

  • 6. High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation.
    Akao Y, Banno Y, Nakagawa Y, Hasegawa N, Kim TJ, Murate T, Igarashi Y, Nozawa Y.
    Biochem Biophys Res Commun; 2006 Apr 21; 342(4):1284-90. PubMed ID: 16516161
    [Abstract] [Full Text] [Related]

  • 7. The sphingosine kinase-1 survival pathway is a molecular target for the tumor-suppressive tea and wine polyphenols in prostate cancer.
    Brizuela L, Dayon A, Doumerc N, Ader I, Golzio M, Izard JC, Hara Y, Malavaud B, Cuvillier O.
    FASEB J; 2010 Oct 21; 24(10):3882-94. PubMed ID: 20522783
    [Abstract] [Full Text] [Related]

  • 8. Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes.
    Tao R, Zhang J, Vessey DA, Honbo N, Karliner JS.
    Cardiovasc Res; 2007 Apr 01; 74(1):56-63. PubMed ID: 17320845
    [Abstract] [Full Text] [Related]

  • 9. First evidence of sphingosine 1-phosphate lyase protein expression and activity downregulation in human neoplasm: implication for resistance to therapeutics in prostate cancer.
    Brizuela L, Ader I, Mazerolles C, Bocquet M, Malavaud B, Cuvillier O.
    Mol Cancer Ther; 2012 Sep 01; 11(9):1841-51. PubMed ID: 22784711
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of sphingosine-1-phosphate lyase rescues sphingosine kinase-1-knockout phenotype following murine cardiac arrest.
    Gorshkova IA, Wang H, Orbelyan GA, Goya J, Natarajan V, Beiser DG, Vanden Hoek TL, Berdyshev EV.
    Life Sci; 2013 Sep 17; 93(9-11):359-66. PubMed ID: 23892195
    [Abstract] [Full Text] [Related]

  • 11. Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models.
    Rosa R, Marciano R, Malapelle U, Formisano L, Nappi L, D'Amato C, D'Amato V, Damiano V, Marfè G, Del Vecchio S, Zannetti A, Greco A, De Stefano A, Carlomagno C, Veneziani BM, Troncone G, De Placido S, Bianco R.
    Clin Cancer Res; 2013 Jan 01; 19(1):138-47. PubMed ID: 23166225
    [Abstract] [Full Text] [Related]

  • 12. Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug.
    Guillermet-Guibert J, Davenne L, Pchejetski D, Saint-Laurent N, Brizuela L, Guilbeau-Frugier C, Delisle MB, Cuvillier O, Susini C, Bousquet C.
    Mol Cancer Ther; 2009 Apr 01; 8(4):809-20. PubMed ID: 19372554
    [Abstract] [Full Text] [Related]

  • 13. Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis.
    Pchejetski D, Kunduzova O, Dayon A, Calise D, Seguelas MH, Leducq N, Seif I, Parini A, Cuvillier O.
    Circ Res; 2007 Jan 05; 100(1):41-9. PubMed ID: 17158340
    [Abstract] [Full Text] [Related]

  • 14. Sphingosine kinase 1 plays a role in the upregulation of CD44 expression through extracellular signal-regulated kinase signaling in human colon cancer cells.
    Kawahara S, Otsuji Y, Nakamura M, Murakami M, Murate T, Matsunaga T, Kanoh H, Seishima M, Banno Y, Hara A.
    Anticancer Drugs; 2013 Jun 05; 24(5):473-83. PubMed ID: 23426175
    [Abstract] [Full Text] [Related]

  • 15. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen.
    Schröder M, Richter C, Juan MH, Maltusch K, Giegold O, Quintini G, Pfeilschifter JM, Huwiler A, Radeke HH.
    Mol Immunol; 2011 May 05; 48(9-10):1139-48. PubMed ID: 21435724
    [Abstract] [Full Text] [Related]

  • 16. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells.
    Shin KO, Seo CH, Cho HH, Oh S, Hong SP, Yoo HS, Hong JT, Oh KW, Lee YM.
    Arch Pharm Res; 2014 May 05; 37(9):1183-92. PubMed ID: 24687256
    [Abstract] [Full Text] [Related]

  • 17. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1.
    Schnute ME, McReynolds MD, Kasten T, Yates M, Jerome G, Rains JW, Hall T, Chrencik J, Kraus M, Cronin CN, Saabye M, Highkin MK, Broadus R, Ogawa S, Cukyne K, Zawadzke LE, Peterkin V, Iyanar K, Scholten JA, Wendling J, Fujiwara H, Nemirovskiy O, Wittwer AJ, Nagiec MM.
    Biochem J; 2012 May 15; 444(1):79-88. PubMed ID: 22397330
    [Abstract] [Full Text] [Related]

  • 18. Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression.
    Bektas M, Jolly PS, Müller C, Eberle J, Spiegel S, Geilen CC.
    Oncogene; 2005 Jan 06; 24(1):178-87. PubMed ID: 15637591
    [Abstract] [Full Text] [Related]

  • 19. Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells.
    Nava VE, Hobson JP, Murthy S, Milstien S, Spiegel S.
    Exp Cell Res; 2002 Nov 15; 281(1):115-27. PubMed ID: 12441135
    [Abstract] [Full Text] [Related]

  • 20. Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
    Wang S, Liang Y, Chang W, Hu B, Zhang Y.
    Med Sci Monit; 2018 Apr 01; 24():1912-1923. PubMed ID: 29605826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.